-
Product Insights
NewNet Present Value Model: Sanofi’s Tolebrutinib
Empower your strategies with our Net Present Value Model: Sanofi's Tolebrutinib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Etrumadenant in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Etrumadenant in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Etrumadenant in Metastatic Ovarian Cancer Drug Details: AB-928 is under...
-
Product Insights
NewThrombosis – Drugs In Development, 2024
Empower your strategies with our Thrombosis – Drugs In Development, 2024 report and make more profitable business decisions. Thrombosis is the formation of a blood clot, known as a thrombus, within a blood vessel. This clot can obstruct the normal blood flow, potentially leading to various health complications. Thrombosis can occur in both veins and arteries. Common types include Deep Vein Thrombosis (DVT), where clots form in deep veins, often in the legs, and Pulmonary Embolism (PE), which occurs when a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Otenaproxesul in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Otenaproxesul in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Otenaproxesul in Pain Drug Details: ATB-346 (otenaproxesul) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Otenaproxesul in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Otenaproxesul in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Otenaproxesul in Osteoarthritis Pain Drug Details: ATB-346 (otenaproxesul) is under development for...
-
Product Insights
Tenblock – 155 Antibes Residential Development – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Tenblock - 155 Antibes Residential Development - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Bone Grafts and Substitutes Pipeline Market Report Overview Bone grafts and substitutes are used in surgical procedures of bones in the human body. It is used in two cases either when there is a breakage in the bone or in the case of a void between or in the bones due to several factors such as age and degenerative diseases. Bone graft substitutes are synthetic substances that are an alternative to bone allografts and autografts. Allograft Bone Chips, Bone Morphogenetic...
-
Product Insights
Net Present Value Model: Otenaproxesul
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Otenaproxesul Drug Details ATB-346 (otenaproxesul) is...
-
Sector Analysis
Orthobiologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. The orthobiologics category covers bone graft substitutes, bone growth stimulators, cartilage repair and viscosupplementation products. The orthobiologics pipeline market research report provides comprehensive information about the orthobiologics pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteoarthritis Pain Pipeline Drugs Market Overview Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain – Drugs In Development, 2022, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape. Osteoarthritis Pain Pipeline Drugs Market is the most common symptom associated with osteoarthritis which causes disruption of the cartilage. If the condition worsens, it leads to rubbing of the bones against each other causing even more pain and loss of movement. Risk factors are age, joint...